Crystallographers receive a boost
12 June, 2003 by Melissa TrudingerMelbourne's protein crystallographers have received a boost with the recent acquisition of a $AUD720,000 X-ray Crystallography generator system at the Austin Research Institute (ARI).
How M&A could raise biotech's living dead
11 June, 2003 by Pete YoungSome Australian listed biotechs are trapped in a death spiral. Shareholders are reluctant to top up their original investments, while cash burn rates tip them ever closer to the edge of insolvency. But there are bright spots, writes Pete Young
Cause for cheer, cause for gloom
10 June, 2003 by Jeremy TorrTwo dedicated market watchers have decreed that it is time for an upturn in the biotech sector, not just in the US but in Australia too. But local fund managers may not yet have the ticker to make it happen.
Monash boosts commerce
10 June, 2003 by Jeremy Torr“Monash is making a major commitment to the commercialisation process. We have gone out on a limb in many ways, in doing what we have done.”
Novogen flexes patent muscles
10 June, 2003 by Jeremy TorrNovogen’s US-based licensee The Solae Company has filed patent infringement suits against two of America’s biggest dietary and health supplement makers.
Xcell's hair analysis gets German nod
06 June, 2003 by Jeremy TorrXcell has received European regulatory approval for its video-dermatoscope hair analysis expert system, designed to replace the traditional and painful trichographic method.
'Baker Biopolis' opens doors with first networking event
05 June, 2003 by Melissa TrudingerMelbourne's Alfred Medical Research and Education Precinct (AMREP), locally known as the Baker Biopolis, kicked off last night with its first networking event aimed to bring researchers at AMREP's Baker and Burnet Institutes together with the companies located in the precinct.
Nominations open for major science awards
04 June, 2003 by Susan WilliamsonNominations are now open for the Australian Academy of Technological Sciences and Engineering's Clunies Ross award for 2004.
NSW minister to recruit research strategy panel
02 June, 2003 by Iain ScottNew South Wales science minister Frank Sartor has continued to boost the state's commitment to research by calling for a panel of eminent researchers to help develop a medical research strategy for the state.
Company founder Manusu seeking to oust Gradipore directors
30 May, 2003 by Iain ScottGradipore director John Manusu, one of the founders of the Sydney company, has called for a general meeting on June 30 to remove the other four directors and elect two new ones.
VRI founder falls on his sword
30 May, 2003 by Iain ScottLeon Ivory, the founder of Perth-based VRI BioMedical, resigned last night, effectively bringing to a close two months of sometimes bitter feuding between the company's board and one of its largest shareholders.
Cephalon takeover bid for Sirtex fails
28 May, 2003 by Jeremy TorrSirtex shareholders watched their stocks slump today as potential takeover candidate Cephalon pulled out after acceptance had not reached the stated 90 per cent condition.
IDT surprised by Virax claim
27 May, 2003 by Jeremy TorrA claim from Virax Holdings that it had been approached by Melbourne company Institute of Drug Technology with a view to a full takeover, has taken IDT managing director Graeme Blackman by surprise.
Dow boosts nanotech interests with Starpharma subsidiary appointments
27 May, 2003 by Melissa TrudingerUS giant Dow Corning's investment in Australian nanotechnology has deepend with a series of high-profile Dow-related appointments to the board and management of Starpharma's US subsidiary Dendritic Nanotechnologies.
Humira gets the nod in Europe
23 May, 2003 by Jeremy TorrPeptech-licensed monoclonal antibody Humira, produced by pharma Abbott, has been granted a positive opinion for the treatment of rheumatoid arthritis in Europe.
